Method for building overexpression MGST1 gene human lung adenocarcinoma cells and application thereof

A technology of MGST1, lung adenocarcinoma cell line, applied in the field of bioengineering, can solve the problems of unexplained mechanism, poor prognosis, increased expression, etc.

Inactive Publication Date: 2018-04-20
信雅生物科技(苏州)有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The technical effect of this patented technology allows researchers to better analyze how certain genes are involved with causing cancer. This helps them identify possible ways by which these genes may help explain their functions or cause diseases such as pulmonary carcinomas.

Problems solved by technology

This patented technical problem addressed in this patent relates to developing novel treatments or diagnostic tools for lung cancers like Non Small Cell Lung Cancer Group IIA (NCIBLC). Current approaches involve invasive procedures involving exploring different areas within the body before they develop symptoms but these techniques may be limited due to their limitations including lack of specific markers associated with each area. To address this issue, there was developed a technique called gene fusion where engineered yeast expressing certain proteins were introduced into normal brain glioblastoma patients through viruses. However, current strategies require expensive equipment and long periods of time, making them difficult to use clinically.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for building overexpression MGST1 gene human lung adenocarcinoma cells and application thereof
  • Method for building overexpression MGST1 gene human lung adenocarcinoma cells and application thereof
  • Method for building overexpression MGST1 gene human lung adenocarcinoma cells and application thereof

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0036] Embodiment 1: Construction of recombinant eukaryotic expression vector pcDNA3-MGST1

[0037] 1. Cloning of MGST1 target gene.

[0038] (1) Design primers for MGST1 overexpression.

[0039] According to the coding sequence of Gene Bank, use primer premier 5 software to design the upstream primer of MGST1 overexpression primer: 5'-CCCAAGCTTGGCTTGCTGCTTCCTCCTC-3' (containing Hind III restriction enzyme cutting site CCCAAGCTT),

[0040] And downstream primer: 5'-CGGGGTACCCCCTCTGCTCCCCTCCTACCT-3' (contains Kpn I restriction site CGGGGTACC)

[0041] (2) The MGST1 target gene was synthesized by PCR.

[0042] The conditions and system of the PCR reaction were set as follows:

[0043] Reaction conditions: pre-denaturation: 98°C 10s; denaturation: 98°C 10s, annealing: 60°C 15s,

[0044] Extension: 72°C for 45s, a total of 33 cycles; store at 4°C.

[0045] reaction system HS DNA Polymerase (Takara)

[0046] The substance of the reaction system

corresponding volume

specific Embodiment approach 2

[0083] Embodiment 2: Construction of human lung adenocarcinoma cells stably overexpressing MGST1 gene

[0084] 1. Cell culture.

[0085] Use RPMI-1640 Medium medium (purchased from GIBCO) containing 10% fetal bovine serum at 37°C, 5% CO 2 The human lung adenocarcinoma cell line SPC-A-1 (purchased from ATCC, USA) was cultured in a cell culture incubator until the culture flask was confluent.

[0086] 2. Eukaryotic expression plasmid pcDNA3-MGST1 was transfected into human lung adenocarcinoma SPC-A-1 cell line.

[0087] Step1: after the SPC-A-1 cells in the logarithmic growth phase were digested with trypsin, a single cell suspension was prepared, and the cells were counted.

[0088] Step2: Seed SPC-A-1 cells in a 6-well plate (approximately 5.0×10 per well 5 Cells) were used for transfection after 12-24 h of inoculation, and were divided into liposome negative control group labeled Lip2000, pcDNA3 plasmid transfection control group (pcDNA3) and pcDNA3-MGST1 recombinant plasmid

specific Embodiment example 3

[0128] Specific implementation case 3: Detection of MGST1 target gene expression by Western bolt

[0129] 1. Total protein extraction (operated on ice).

[0130] Collect the cells in a centrifuge tube and centrifuge at 2000rpm for 4min, wash twice with pre-cooled PBS, add an appropriate volume of RIPA (10μl / ml protease inhibitor and phosphatase inhibitor) according to the cell volume, mix by pipetting, and seal the EP tube After the membrane was sealed, put it in a cell disruption ultrasonic instrument at 4°C, 500watt, lyse for 20min; centrifuge at 14000g, 20min, to precipitate cell debris, extract the supernatant and transfer it to an EP tube, and store it at -80°C for later use.

[0131] 2. BCA protein quantification method was used to determine the protein content.

[0132] Dilute the 2mg / ml protein standard stock solution in multiple ratios, and the diluted protein standard concentrations are: 2mg / ml, 1mg / ml, 0.5mg / ml, 0.25mg / ml, 0.125mg / ml; in the BCA kit Sol

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a method for building stable overexpression MGST1 gene cells and primarily studying the biological characteristics of the cells. The method comprises the following steps of (1)synthesizing human MGST1 target gene segments through PCR; (2) connecting the MGST1 target gene segments with eukaryotic plasmid pcDNA3 to form eukaryotic recombinant plasmids; converting the eukaryotic recombinant plasmids into sensory bacterial cells to be cultured; and then selecting monoclone for performing PCR amplification gel electrophoresis to screen out positive clone; (3) extracting thepositive clone screened out from the step (2); analyzing the built eukaryotic recombinant plasmids by using a restriction enzyme double digestion atlas; and performing DNA sequence analysis; and (4) transfecting SPC-A-1 human lung adenocarcinoma cells by the recombinant plasmids pcDNA3-MGST1 with the correct sequence obtained in the step (3); screening SPC-A-1 cells for stably overexpressing MGST1by using G418; and observing the biological characteristics of the cells for stably overexpressing MGST1. The result shows that through the stable overexpression of the MGST1, the cell proliferationcan be promoted; the cell apoptosis can be inhibited; and the cell clone formation capability can be enhanced.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner 信雅生物科技(苏州)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products